Formulation of piperine solid lipid nanoparticles (SLN) for treatment of rheumatoid arthritis

Abstract

The purpose of this work was to formulate piperine solid lipid nanoparticle (SLN) dispersion to exploit its efficacy orally and topically. Piperine SLN were prepared by melt emulsification method and formula was optimized by the application of 3² factorial design. The nanoparticulate dispersion was evaluated for particle size, entrapment efficiency and zeta potential (ZP). Optimized batch (128.80 nm average size, 78.71% entrapment efficiency and −23.34 mV zeta potential) was characterized for differential scanning calorimetry (DSC), X-ray diffraction which revealed amorphous nature of piperine in SLN. The prepared SLN were administered orally and topically to CFA-induced arthritic rats. Ex vivo study using Franz diffusion cell indicate that piperine from SLN gel formulation accumulates in the skin. Pharmacodynamic study result indicates both the topical and oral piperine evoked a significant response compared to orally administered chloroquine suspension. The results of ELISA show significant reduction in TNFα in treated rat which might be the reason behind the DMARD action of piperine SLN.

Keywords:

• Rheumatoid arthritis
• piperine
• SLN (solid lipid nanoparticles)
• optimization
• TNFα
• ELISA
• CIA

Acknowledgements

The authors are thankful to AISSMS College of pharmacy, Pune for providing a facilities to carry out the research work.

Disclosure statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.